M
MEDU LABORATORIES
Vendor Ledger/Accelerate Labs
A

Accelerate Labs

AExcellent 37 products · 52 certificates

Products examined

ProductRating Samples Avg MinMaxLatest
Ipamorelin A 3 8.6 7.0 9.6 16 May 2025
GHK-Cu A 2 7.2 7.2 7.2 10 Jul 2025
Semaglutide A 3 7.3 7.1 7.6 16 May 2025
Retatrutide C 3 5.8 4.1 6.9 16 May 2025
CJC-1295 D 4 6.8 3.6 10.0 16 May 2025
BPC-157 D 3 5.1 3.9 5.9 16 May 2025
Melanotan II E 2 2.0 2.0 2.0 16 May 2025
ACE-031 X 1 5.2 5.2 5.2 21 May 2025
Adipotide A 2 5.8 4.3 7.4 26 Jan 2026
AHK-CU A 2 4.6 4.5 4.7 24 May 2026
AICAR A 2 6.1 5.7 6.4 21 May 2026
Botulinum toxin X 1 7.2 7.2 7.2 3 Jun 2025
Cardiogen A 2 6.5 5.6 7.5 20 May 2026
Cerebrolysin X 1 6.6 6.6 6.6 27 Feb 2025
CJC-1295 With DAC A 2 6.2 5.4 6.9 26 Jan 2026
Epithalon A 2 7.5 6.4 8.5 24 May 2026
HMG X 1 5.1 5.1 5.1 24 Apr 2025
Hyaluronic acid A 2 5.4 4.0 6.8 20 May 2026
KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg A 2 8.0 6.1 9.9 20 May 2026
KPV A 2 6.9 6.8 7.0 21 May 2026
Letrozole X 1 6.3 6.3 6.3 9 Jun 2025
Liraglutide X 1 5.4 5.4 5.4 17 Dec 2024
Methylstenbolone A 2 7.7 6.6 8.8 25 May 2026
Ostarine (MK-2866) X 1 7.0 7.0 7.0 2 Jul 2025
P21 X 1 4.6 4.6 4.6 25 Apr 2025
PE 22-28 A 2 9.2 8.7 9.7 21 May 2026
Phenylacetic acid CAS 103-82-2 X 1 6.9 6.9 6.9 8 Jul 2025
PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 A 2 5.0 5.0 5.0 21 May 2026
Retatrutide 30mg Pen Kit A 2 5.0 3.5 6.6 25 May 2026
Salbutamol X 1 6.6 6.6 6.6 24 Apr 2025
Selank 10mg + Semax 10mg Blend A 2 6.2 5.8 6.7 19 Jan 2026
Semaglutide Oral X 1 4.6 4.6 4.6 17 Dec 2024
Superdrol X 1 7.7 7.7 7.7 21 May 2025
T4 (Levothyroxine) A 2 5.4 5.2 5.6 19 Jan 2026
Test Suspension X 1 8.2 8.2 8.2 13 Jun 2025
Tren Hex X 1 5.5 5.5 5.5 27 Feb 2025
Trestolone Acetate (MENT) Raw X 1 7.7 7.7 7.7 14 Jan 2025

The certificates

DateProductScoreDeclared MeasuredDeviationPurityLaboratory
24 May 2026 Ostarine (MK-2866) 6.7 25mg 26.5mg +5.9% 96.65% Lab G
24 May 2026 ACE-031 4.0 50mg 57.7mg +15.5% 97.88% Lab F
24 May 2026 Hyaluronic acid 4.5 30mg 32.7mg +8.8% 98.19% Lab E
24 May 2026 Retatrutide 30mg Pen Kit 4.2 50mg 60.0mg +20.1% 95.46% Lab B
24 May 2026 Selank 10mg + Semax 10mg Blend 6.9 20mg 19.5mg -2.3% 96.18% Lab E
24 May 2026 Semaglutide Oral 4.0 25mg 22.8mg -8.8% 95.87% Lab B
24 May 2026 AHK-CU 5.2 5mg 5.5mg +9.0% 98.36% Lab C
24 May 2026 PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 4.9 100g 87.9g -12.1% 95.05% Lab A
23 May 2026 Phenylacetic acid CAS 103-82-2 8.5 1g 1.2g +23.7% 95.43% Lab B
23 May 2026 KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg 9.0 5mg 5.4mg +7.8% 99.95% Lab D
21 May 2026 Cerebrolysin 6.4 30mg 35.2mg +17.4% 97.00% Lab B
21 May 2026 CJC-1295 With DAC 7.5 5mg 4.9mg -1.6% 96.59% Lab B
20 May 2026 HMG 6.1 5mg 4.8mg -4.0% 99.15% Lab B
20 May 2026 PE 22-28 9.3 5mg 4.3mg -14.5% 97.35% Lab F
19 May 2026 Superdrol 7.1 10mg 10.9mg +8.8% 97.71% Lab E
17 May 2026 P21 5.3 20mg 18.1mg -9.4% 97.02% Lab E
17 May 2026 Salbutamol 5.5 100mg 86.4mg -13.6% 97.82% Lab A
17 May 2026 Selank 10mg + Semax 10mg Blend 5.5 20mg 23.1mg +15.6% 99.25% Lab A
29 Jan 2026 KPV 7.2 20mg 24.8mg +23.8% 97.49% Lab F
29 Jan 2026 Retatrutide 30mg Pen Kit 6.0 50mg 62.0mg +23.9% 98.19% Lab B
26 Jan 2026 Cardiogen 9.7 20mg 24.3mg +21.6% 95.92% Lab A
26 Jan 2026 Epithalon 7.3 50mg 51.3mg +2.5% 95.64% Lab F
26 Jan 2026 Letrozole 6.5 20mg 23.0mg +14.9% 99.98% Lab D
19 Jan 2026 Methylstenbolone 7.2 20mg 18.9mg -5.3% 97.78% Lab D
9 Jan 2026 AHK-CU 4.8 50mg 59.7mg +19.5% 95.53% Lab D
7 Jan 2026 Tren Hex 5.3 100mg/ml 101.8mg/ml +1.8% 97.68% Lab A
6 Jan 2026 CJC-1295 With DAC 4.0 10mg 10.7mg +6.9% 99.56% Lab B
6 Jan 2026 KPV 7.0 10mg 9.7mg -3.2% 97.02% Lab A
29 Dec 2025 Adipotide 6.4 15mg 16.4mg +9.7% 99.86% Lab A
12 Dec 2025 Test Suspension 6.2 100mg/ml 115.0mg/ml +15.0% 98.34% Lab F
5 Dec 2025 AICAR 6.9 20mg 17.6mg -11.9% 97.28% Lab D
5 Dec 2025 AICAR 5.6 30mg 29.6mg -1.5% 99.58% Lab G
5 Dec 2025 Liraglutide 5.8 30mg 25.6mg -14.8% 96.94% Lab B
17 Nov 2025 Adipotide 5.9 30mg 32.3mg +7.6% 96.48% Lab C
14 Nov 2025 Epithalon 6.1 15mg 15.8mg +5.6% 97.74% Lab A
14 Nov 2025 PMK ethyl glycidate (3,4-MDP-2-P ethyl glycidate) CAS 28578-16-7 4.1 1g 1.2g +20.7% 96.68% Lab F
14 Nov 2025 Trestolone Acetate (MENT) Raw 9.6 10g 10.4g +4.3% 99.44% Lab F
5 Nov 2025 Botulinum toxin 9.1 30mg 29.7mg -1.1% 98.59% Lab E
5 Nov 2025 T4 (Levothyroxine) 6.3 100mg 96.5mg -3.5% 96.07% Lab D
4 Nov 2025 KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg 8.7 5mg 5.6mg +12.5% 95.00% Lab E
17 Oct 2025 Hyaluronic acid 5.7 30mg 33.2mg +10.7% 96.32% Lab D
17 Oct 2025 Methylstenbolone 9.4 10mg 9.0mg -10.5% 99.44% Lab C
9 Oct 2025 Cardiogen 7.9 10mg 8.7mg -13.3% 96.65% Lab E
9 Oct 2025 PE 22-28 9.6 2mg 2.0mg +2.3% 98.81% Lab F
3 Oct 2025 T4 (Levothyroxine) 6.3 25mg 28.5mg +13.9% 96.08% Lab G
6 Sep 2025 Ipamorelin 7.0 5mg (no batch claim) 4.2mg -16.0% White Label / Silver Crimp / Blue Cap
25 Jul 2025 BPC-157 3.9 5mg (no batch claim) 6.4mg +28.0% White Label /Silver Crimp / Purple Cap
23 Jul 2025 Retatrutide 4.1 10mg 11.0mgwebsite 9.2mg -16.4% White Label /Silver Crimp / Dark Blue Cap
22 Jul 2025 Semaglutide 7.6 5mg 5.2mgwebsite 4.7mg -9.4% White Label / Silver Crimp / Blue Cap
10 Jul 2025 GHK-Cu 7.2 50mg (no batch claim) 59.4mg +18.8% White Label /Silver Crimp / Red Cap
10 Jul 2025 GHK-Cu 7.2 50mg (no batch claim) 59.2mg +18.4% White Label /Silver Crimp / Red Cap
16 May 2025 Melanotan II 2.0 10mg ⚠️ Sample does not contain Melanotan II ? 06-26-2024 White Label /Silver Crimp / Yellow Cap